Clinical trial
The Effect of Probiotics on Intestinal Barrier Function and Intestinal Flora in Infants With Congenital Heart Disease Undergoing Cardiopulmonary Bypass
NCT06295575 is registered in ClinicalTrials.gov with Nanjing Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Probiotics on Intestinal Barrier Function and Intestinal Flora in Infants With Congenital Heart Disease Undergoing Cardiopulmonary Bypass
- Lead sponsor
- Nanjing Children's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2021
- Completion date
- July 1, 2022
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease, dysbiosis, intestinal disease